Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
MIT scientists’ AI model one-ups AlphaFold 3, takes on ‘fundamental issue’ in drug R&D
Last month
AI
Pharma imports into the US return to normal after March tariff stockpiling
Last month
Pharma
Manufacturing
At a crossroads, biotechs are passing on reverse mergers in 2025
Last month
Financing
Deals
Otsuka spells out Phase 3 win in rare kidney disease, Vera’s stock takes a hit
Last month
R&D
Biopharma leaders carving a path for the industry’s LGBTQ+ community
Last month
People
Special
GSK taps Sanofi vet to lead vaccine R&D; Bristol Myers names head of corporate affairs
Last month
Peer Review
Omada Health is going public at a $1.1B valuation
Last month
Financing
Health Tech
Biotech ranks as China’s best shot to surpass US in emerging tech, report finds
Last month
China
Pharma
FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees
Last month
Cell/Gene Tx
FDA+
CMS talks health tech
Last month
Health Tech
Trump's health appointees pledge support for cell and gene therapies at FDA roundtable
Last month
Cell/Gene Tx
FDA+
A decade after its ill-fated $40.5B megadeal, Teva pivots from generics to innovation
Last month
R&D
Pharma
Schott Pharma's €100M+ Hungary expansion; Antheia’s $56M Series C raise
Last month
Manufacturing
Corcept plots future for ALS drug that flunked Phase 2, citing survival analysis
Last month
R&D
FDA's Prasad explains rationale behind pausing Valneva's chikungunya vaccine in seniors
Last month
FDA+
Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug
Last month
News Briefing
Regenxbio says Duchenne gene therapy improved motor skills in five patients
Last month
R&D
Cell/Gene Tx
Ex-Amazon employees are betting their new venture changes online shopping for healthcare
Last month
Startups
Health Tech
Anne Wojcicki and Regeneron set to duke it out in restarted 23andMe auction
Last month
Deals
Pharma
Exclusive: Allay reaches $57.5M Series D milestone for post-surgical pain drug
Last month
Financing
Startups
Exclusive: Tech VC Amplify raises $200M for first biotech fund, hires Elliot Hershberg as new partner
Last month
Financing
Startups
Digital health startup Virta stakes fees on curbing GLP-1 prescriptions
Last month
Startups
Health Tech
In a first, Sarepta announces platform technology designation for gene therapy vector
Last month
Cell/Gene Tx
FDA+
Exclusive: After cutting most staff, Casma eyes path to clinic with its first autophagy-boosting drug
Last month
R&D
Pharma
First page
Previous page
10
11
12
13
14
15
16
Next page
Last page